Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany

BACKGROUND: The VEGF Inhibition Study In Ocular Neovascularisation (VISION) reported the efficacy of intravitreal (ITV) vascular endothelial growth factor (VEGF) inhibition with pegaptanib sodium (Macugen(®)) for the treatment of neovascular age-related macular degeneration (AMD). This paper reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Feucht, Nikolaus, Matthias, Huebner, Lohmann, Chris P, Maier, Mathias
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693993/
https://www.ncbi.nlm.nih.gov/pubmed/19668713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693993/
https://www.ncbi.nlm.nih.gov/pubmed/19668713

Ejemplares similares